DIA Europe 2027 • Basel, Switzerland
Keynote Speaker and Plenary Sessions
Reimagining healthcare innovation starts with challenging the way we think. Discover fresh perspectives, bold ideas, and thought-provoking discussions exploring the challenges and opportunities facing the global life sciences community.
Who Will Win the Life Sciences Race: Europe, the US or China?
As global competition for scientific talent, investment, and innovation intensifies, where does Europe stand? This plenary will open with a leading economist’s perspective on the macroeconomic performance and competitive strengths of Europe, the US, and China, before exploring what these dynamics mean for healthcare and the life sciences sector. The discussion will examine the challenges of turning scientific excellence into globally competitive businesses, from securing biotech financing to scaling breakthrough innovations. What can Europe learn from the US and China, and what will it take to strengthen its position in the global life sciences landscape?
Keynote Speaker
Arturo Bris
Professor of Finance at IMD and Director of the IMD World Competitiveness Center
View bio
Arturo Bris is an internationally recognized expert in global competitiveness, finance, and geopolitics. As Director of the IMD World Competitiveness Center in Lausanne, Switzerland, he works with governments and business leaders worldwide to assess the factors driving economic competitiveness, innovation, and long-term growth.
An award-winning professor, researcher, and frequent speaker at international conferences, Arturo brings extensive experience in corporate governance, financial regulation, and the relationship between economic policy and competitiveness. His research has appeared in leading academic journals, and his insights are regularly featured in international media.
At DIA Europe 2027, Arturo will bring a fresh perspective on global competitiveness to the opening plenary, exploring the forces driving innovation and what they mean for Europe's position in the international life sciences landscape.
Will AI Reinvent Pharma or Replace It?
AI is reshaping how we understand biology, discover medicines, and develop new treatments. But how much of its promise is already becoming reality? Featuring two presentations - one offering the perspective of a leading AI company and the other that of a pharmaceutical company - this plenary will examine the potential of AI to transform drug discovery, clinical development, and the pharmaceutical business model. Together, these perspectives will help distinguish scientific progress from speculation and explore what AI’s growing role could mean for patients.
The Next Frontier in Medicine: From Treating Disease to Delivering Cures
Advances in cell engineering and next-generation therapies are opening new possibilities for treating, and potentially curing, disease. But what will it take to translate scientific breakthroughs into treatments that reach patients? This plenary will explore the challenges of development, manufacturing, and healthcare delivery, and what must change to make these innovations part of routine care.
Progress needs every perspective. Bring yours!
All plenary sessions are included with basic and regular DIA Europe 2027 registration.
16–18 March 2027 • Basel, Switzerland